Rocket, Labs

Rocket Lab's Synspective Deal Locks In 20 Electron Launches as Analysts Split on Valuation

Published on 10/12/2026 at 14:50 | Editorial boerse-global.de

Rocket Lab booked 20 Electron launches for Synspective through 2031, lifting its manifest to 47 missions, as analysts diverge on the stock's target.

Rocket Lab Wins 20-Launch Synspective Deal as Barclays and TD Cowen Split on Valuation
Rocket Lab's Synspective Deal Locks In 20 Electron Launches as Analysts Split on Valuation Illustration mit AI erstellt.

Rocket Lab has secured the largest single commercial contract in the history of its Electron rocket, agreeing to carry out 20 dedicated launches for Japanese Earth-imaging specialist Synspective between 2028 and 2031. The multi-year booking, announced on September 30, lifts Synspective's total manifest with the company to 47 Electron missions and hands the launch provider a predictable revenue stream stretching well into the next decade.

Chief executive Peter Beck framed the agreement as a vote of confidence in Rocket Lab's launch cadence, reliability and orbital insertion precision — credentials that carry extra weight in a market where rivals are still wrestling with delays.

Two Banks, Two Signals

The deal landed just as Wall Street delivered a split verdict on the stock. Barclays initiated coverage on Friday, October 9, with an "Overweight" rating and an $85 price target. On the same day, TD Cowen's Gautam Khanna trimmed his target to $90 from $120 while keeping his "Buy" recommendation intact, describing the broader sector downgrade as disorderly.

The pair of calls captures the tension now shaping the investment case: analysts see genuine upside, yet they are tightening their valuation assumptions. The market has taken note. The shares changed hands at €60.70, roughly 55% below their 52-week high of €133.80 — a peak reached at the end of May. Pre-market trading put the price near €61.10.

Should investors sell immediately? Or is it worth buying Rocket Lab?

A Sector-Wide Repricing, Not a Company-Specific Shock

The retreat is not unique to Rocket Lab. AST SpaceMobile and Planet Labs have absorbed comparable losses as rising US Treasury yields and climbing crude oil prices drain appetite for capital-intensive growth names. No company-specific bad news drove the selloff, according to media accounts — the pressure came from macro forces that tend to hit space ventures hardest, given their heavy funding needs and sensitivity to a restrictive rate environment.

TD Cowen's characterization of the sector reset as disorderly underscores a blunt reality: fundamental progress can be drowned out in the short term by macroeconomics. Should bond yields stay elevated, the discount rates applied to future earnings will keep squeezing valuations.

Insider Sale Follows a Pre-Set Script

Adding a layer of scrutiny, chief financial officer Adam Spice exercised options on 140,157 shares on October 1 and sold the same number of shares that day. SEC filings show the transaction was executed under a Rule 10b5-1 trading plan established on June 3, 2026 — the kind of pre-scheduled arrangement that is standard practice at US corporations but still draws attention when volatility is high, since it inevitably raises questions about how management views near-term prospects.

Chart Levels and the Road to Launch 100

Technically, the stock is hovering just under its 50-day moving average of €61.38, about 0.5% below that line. Holding this level in reach keeps the door open to stabilization; a decisive break lower, coupled with continued weakness across space equities, could set up a retest of deeper territory.

On the operational calendar, the next hard milestone is Rocket Lab's 100th Electron launch, for which the company has announced accreditations. The anniversary mission is slated for November 2026 in New Zealand, subject to scheduling changes. Pulling it off would demonstrate that the company can sustain its launch tempo even when market conditions swing.

For now, the contest between bullish analyst calls and macro headwinds remains the dominant force steering the stock. The Electron's commercial backlog — now anchored by a 47-mission commitment from a single customer — offers the fundamental ballast. The open question is whether Rocket Lab can convert that technical maturity into durable profitability, and whether its operating pace can keep stride with its hefty investment costs. Until then, the shares are likely to stay in the shadow of their former highs.

Ad

Rocket Lab Stock: New Analysis - 12 October

Fresh Rocket Lab information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Rocket Lab analysis...

Disclaimer...

en | US7731211089 | ROCKET | boerse | 70302810 |